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Abstract
Background: Tamoxifen (TAM) is an important cancer therapeutic and an experimental tool for effecting genetic
recombination using the inducible Cre-Lox technique. Despite its widespread use in the clinic and laboratory, we
know little about its effects on the nervous system. This is of significant concern because TAM, via unknown
mechanisms, induces cognitive impairment in humans. A hallmark of cellular stress is induction of Activating
Transcription Factor 3 (Atf3), and so to determine whether TAM induces cellular stress in the adult nervous system,
we generated a knock-in mouse in which Atf3 promoter activity drives transcription of TAM-dependent Cre
recombinase (Cre-ERT2); when crossed with tdtomato reporter mice, Atf3 induction results in robust and permanent
genetic labeling of cells in which it is up-regulated even transiently.
Results: We found that granular neurons of the olfactory bulb and dentate gyrus, vascular cells and ependymal
cells throughout the brain, and peripheral sensory neurons expressed tdtomato in response to TAM treatment. We
also show that TAM induced Atf3 up-regulation through inhibition of cholesterol epoxide hydrolase (ChEH): reporter
expression was mitigated by delivery in vitamin E-rich wheat germ oil (vitamin E depletes ChEH substrates), and
was partially mimicked by a ChEH-specific inhibitor.
Conclusions: This work demonstrates that TAM stresses cells of the adult central and peripheral nervous systems and
highlights concerns about clinical and experimental use of TAM. We propose TAM administration in vitamin E-rich
vehicles such as wheat germ oil as a simple remedy.
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Introduction
Tamoxifen (TAM), a “selective estrogen receptor modula-
tor” (SERM), is among the most widely-used anti-cancer
drugs for women with estrogen receptor-positive breast tu-
mors. Although its side effects have long been considered
minor, there is accumulating evidence that a subpopulation
of TAM-treated patients experience cognitive disturbances
such as confusion, deterioration of verbal memory, and ex-
ecutive function such as decision-making, symptoms often
referred to as “TAM brain fog” [1–4]. Changes in human
brain structure and metabolism with TAM treatment have
also been reported [5]. Yet, there has been surprisingly
little work done in animal models to identify TAM-
induced changes in structure or function of the nervous
system (either central or peripheral) [6], although in
one study it was associated with a loss of glial progeni-
tor cells in the corpus callosum and with reduced cell
division in neurogenic regions of the CNS [7].
The dearth of preclinical work on potential adverse ef-
fects of TAM is concerning not only because of its reported
cognitive effects in humans, but also because TAM is a
widely-used tool for manipulating gene expression in vivo
via the inducible Cre-Lox technique. Cre recombinase is a
bacteriophage enzyme, which can remove sequences of
DNA that lie between engineered loxP sites (referred to as
“floxed” sequences). By attaching Cre to a mutated estrogen
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receptor (ERT2, which binds TAM but not endogenous
estrogens; Cre-ERT2), it is possible to control precisely
when a DNA sequence can be excised. As an example,
mice expressing Cre-ERT2 can be crossed with another
transgenic line containing a floxed “stop” signal preceding
the sequence for a fluorescent reporter. The resulting mice
express Cre-ERT2, which is restricted to the cytoplasm.
When it binds TAM, Cre-ERT2 is translocated to the
nucleus, where it can excise the stop signal, resulting in
reporter expression. This technique has been used in
mice to permanently label newly-generated neurons in the
hippocampus [8] and transiently-active neurons following
exposure to novel environments [9].
What remains little-acknowledged in studies using
the Cre-ERT2 system is that TAM acts at the endogen-
ous estrogen receptor α (ERα), hence its clinical use in
cancer. Furthermore, TAM binds other endogenous mole-
cules, including sigma 1 and 2 receptors on the endoplas-
mic reticulum [10], and cholesterol epoxide hydrolase
(ChEH) – an enzyme complex involved in cholesterol bio-
synthesis [11]. In fact, the affinity of TAM for ChEH is
second only to that for ERα, which may underlie its
counter-intuitive efficacy in ER-negative breast cancers
[11]. TAM thus has the potential to alter neurophysiology
via any one of these avenues.
We generated a knock-in mouse expressing CreERT2
driven by the native promoter for activating transcrip-
tion factor 3 (Atf3), one of a number of transcription
factors upregulated by cellular stress, such as the un-
folded protein response, tyrosine kinase receptor activa-
tion, glutamate receptor hyperactivation, and cellular
injury [12]. Crossing the ATF3-CreERT2 line with floxed
stop ROSA-tdtomato line, when combined with TAM
treatment, allows for permanent labelling of cells even
transiently stressed by TAM. Here we report TAM-
induced recombination in mature granular neurons of the
olfactory bulb and dentate gyrus, populations of neurons
involved in memory formation and recall. Recombination
also occurred in larger-diameter proprioceptive neurons
of the dorsal root ganglion, and in vascular endothelial
and smooth muscle cells, and ependyma throughout the
brain and spinal cord. We also provide evidence that
TAM’s induction of Atf3 expression occurs via ChEH
binding, and not via ERα or sigma 1/2 receptors.
Material and methods
Generation of mice
The mouse Atf3 gene was subcloned from a 129 bacter-
ial artificial chromosome (BAC) (bMQ-293K18) into
pBluescript (approx. 5 kb of sequence either side of the
transcriptional start site in exon 2). Homologous recom-
bination in bacteria was used to insert a construct dir-
ectly after the ATG start codon containing: Cre fused to
the mutated estrogen-ligand binding domain (CreERT2),
1.2 kb of Atf3 3′ untranslated region, a Simian virus 40
stop signal and a neomycin cassette flanked by two FLP-
recognition target sites. The final targeting vector was
sequenced, linearised using a ZraI digest and electropo-
rated into 129 mouse embryonic stem (ES) cells. Posi-
tive clones were identified using Southern blotting after
digest with EcoRV (Fig. 1a) and injected into blasto-
cysts. The ES cell manipulations and blastocyst injec-
tions were carried out by the Transgenic Services of the
Institute of Child Health at University College London.
After breeding out the neomycin resistance gene from
founders using Flp recombinase mice, the main mouse
line was generated and is maintained in a heterozygous
state (ATF3-CreERT2). The ATF3-CreERT2 mice were
crossed with a floxed stop ROSA-tdtomato line (AI14,
Jackson Labs) [13] for characterization of expression.
They are maintained on a mixed background of 129SvEv
and C57BL/6J.
We also used a BAC transgenic mouse in which the
promoter for advillin, expressed in all dorsal root gan-
glion (DRG) neurons, drives CreERT2 [14], and crossed
it with the same reporter line as above. For all experi-
ments, mice in treatment and control groups were sex
and age-matched.
Drug treatments
All of the drugs used, their doses, and final animal
numbers in each experiment are listed in Table 1. TAM
was delivered at a dose of 75 mg/kg intraperitoneal
(i.p.) in multiple vehicles, containing varying amounts
of α-tocopherol (vitamin E), which prevents accumula-
tion of cholesterol epoxides. Sunflower oil (SFO), which
is relatively low in vitamin E (40 mg/100 g), was used
as a TAM vehicle and compared with wheat germ oil
(WGO), which is relatively rich in vitamin E (~150 mg/
100 g) [15]. In some experiments, we added vitamin E
to SFO; vitamin E was dissolved in SFO at a concentra-
tion of 4.47 mg/ml, to match the dose contained in
WGO, chosen based on previous efficacy and toxicity
studies of vitamin E in mice [16]. When delivered in wheat
germ oil (WGO) or sunflower oil (SFO) with vitamin E,
we used a volume of 0.25 ml or 0.5 ml, and gave additional
injections of oil or oil and vitamin E alone on the day be-
fore and the day after TAM treatment.
In experiments designed to identify the mechanism of
TAM-induced ATF-3 up-regulation, we treated mice
with either the anti-estrogen ICI 182,780 (ICI), a “pure”
anti-estrogen [17], 4,4′,4″-(4-Propyl-[1H]-pyrazole-1,3,5-
triyl)trisphenol (PPT), a potent ERα agonist [18], or dito-
lylguanidine (DTG), a sigma-1 and −2 receptor agonist.
ICI 182,780 in SFO (20 μg) [19] or SFO only was adminis-
tered to nerve-injured mice by gavage the day before, the
day of, and the day following TAM (or oil only) treatment.
4,4′,4″-(4-Propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol (PPT),
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was dissolved in 50 % DMSO in PBS and given by
s.c. injection at 10 mg/kg [18] following the same
schedule as with ICI 182,780. The sigma receptor
agonist 1,3-di-o-tolylguanidine (DTG) was prepared as
previously described [20] and delivered by i.p. injec-
tion in the same manner as the above drugs. The se-
lective ChEG ligand N,N-Diethyl-2-[4-(phenylmethyl)
phenoxy]ethanamine hydrochloride (DPPE, also known as
tesmilifene) was administered at a one-time dose of
50 mg/kg i.p. in saline [21]. Control mice received saline-
only injections. For treatments with ICI 182,780, PPT,
DTG, DPPE, and their controls, mice were killed on the
fourth day following treatment.
Tissue processing and analysis
Mice were deeply anesthetized with sodium pentobar-
bital (Euthanal) and perfused transcardially with phos-
phate buffered saline followed by 4 % paraformaldehyde
in 0.1 M phosphate buffer (PB). Tissues were dissected
and transferred to 20 % sucrose in 0.1 M PB. Brains and
spinal cords were embedded in gelatin and cut coronally
on a vibratome (100 μm), or were frozen and cut at
50 μm on a cryostat (for co-localization studies). Whole
dorsal root ganglia or 16 μm-thick cryosections were
processed for immunohistochemistry. For DRG whole-
mounts and brain sections, quantification was carried
out on ~1 μm-thick confocal sections imaged with a
Zeiss LSM 710 confocal system. DRG cryosections were
imaged with a Zeiss AxioObserver Z.1 equipped with a
Yokogawa spinning disk. In the dentate gyrus and
olfactory bulb we measured the density of recombined
neurons in the granular layers of each structure (3 sec-
tions per animal at the level of the median eminence), or
counted recombined neurons (for DPPE studies). In the
DRG we traced recombined profiles and used recursive
translation [22] to convert profile distributions (in which
large profiles are numerically overrepresented and lead
to overestimations of the number of small diameter pro-
files) to cell distributions.
To quantify size-frequency distributions of all DRG neu-
rons, we used cervical DRG whole-mounts from advillin-
CreERT2 mice treated for 3 days with 75 mg/kg TAM in
SFO, and killed on the fourth day. Cell densities between
SFO and WGO groups were compared using Student’s
t-test. Proportions of recombined neurons in the DRG
were compared with a one-way analysis of variance
(ANOVA) followed by a post-hoc Holm-Sidak test for
pairwise differences. The Kolmogorov-Smirnov goodness-
of-fit test was used to determine whether cell size-
frequency distributions differed significantly.
Antibodies
The following antibodies were used: rabbit anti-ATF3
(1:200, Santa Cruz Biotechnology Inc.), mouse anti-
neurofilament 200 (NF200; clone N52, 1:500, Sigma),
rabbit anti-calcitonin gene related peptide (CGRP; 1:4000,
Sigma), rabbit anti-tyrosine hydroxylase (TH; 1:1000,
Millipore). To identify non-peptidergic nociceptors, slides
were first incubated in isolectin B4 (IB4;1:400, Sigma)
followed by an anti-IB4 primary antibody (1:2000, Vector
(See figure on previous page.)
Fig. 1 Characterization the naïve ATF3-CreERT2:stopfl/fltdtomato mouse. a Genetic strategy used to generate the ATF3 CreERT2 mouse. The
wild-type ATF3 locus (ATF3 wt) was modified to generate a transgenic construct (ATF3 Cre + neo), in which CreERT2 was inserted immediately
after the ATG start codon. Numbers in brackets designate length of fragments in kilobases. The construct was electroporated into 129SvEv
mouse embryonic stem cells and positive clones were selected via neomycin (neo) and identified using Southern blots: three clones are shown as an
example. Positive founders were bred with a flp-expressing line to remove the neomycin cassette, and the final ATF3 Cre mice were crossed with a
ROSA-tdtomato line to yield an ATF3CreERT2 reporter mouse (ATF3 Cre x tdtomato). Schematics are not drawn to scale. b Terminals of trigeminal (left)
and DRG axons (right) in the brainstem and upper cervical cord, respectively (regions in boxes enlarged in b’ and b”). The arrow indicates sensory
axons in the dorsal funiculus. All images are 30 μm-thick confocal orthogonal projections. c A tdtomato-positive sensory neuron from a cervical DRG
(42 μm-thick z-projection). d Rare recombined granular neurons from the dentate gyrus (left) and olfactory bulb (right) (30 μm-thick z-projections).
e Occasional clusters (probably clonal) of microglia (left, here from the cerebellum) and vascular endothelial cells (right, in this case from the midbrain)
(30 μm-thick z-projections)
Table 1 Compounds and doses used in N number of mice
Compound Dose/ Route of administration N
Tamoxifen in sunflower oil 75 mg/kg, i.p. (1 × day or 3 × days) 5
Tamoxifen in wheat germ oil 75 mg/kg, i.p. (1 × day) 4
Vitamin E 4.47 mg/ml in sunflower oil, i.p. 6
ICI 182,780 (ICI) 20 mg/kg, gavage 3
4,4′,4″-(4-Propyl-[1H]-pyrazole-1,3,5-triyl) trisphenol (PPT) 10 mg/kg, s.c. 3
1,3-di-o-tolylguanidine (DTG) 5 mg/kg, i.p. 3
Diethyl-2-[4-(phenylmethyl)
phenoxy]ethanamine hydrochloride (DPPE)
50 mg/kg, i.p. 3
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laboratories). To characterize recombined neurons in the
brain we used mouse anti-Neuronal Nuclei (NeuN; 1:100,
Millipore) and rabbit anti-calbindin d28k (1:1000, Swant).
Secondary antibodies included donkey anti-rabbit Alexa-
488, donkey anti-goat Alexa-647, donkey anti-mouse
Dylight 650 (all at 1:1000, Invitrogen), donkey anti-mouse
aminomethylcoumarin (AMCA; 1:100, Jackson labs). Nu-
clear counterstains were 4′,6-diamidino-2-phenylindole
(DAPI) (in ProLong Gold coverslipping medium, Invitro-
gen) or Hoechst 33342 (1:10,000, Sigma).
Results
Generation and characterization of ATF3-CreERT2:stop
fl/fltdtomato mice
A transgenic knock-in strategy was used to replace the
endogenous Atf3 locus with an ATF3-CreERT2 allele
(Fig. 1a). The resulting mice, even in a homozygous state,
which effectively constitutes an Atf3 knock-out, appear
phenotypically normal and outwardly indistinguishable
from their wild-type littermates. The ATF3-CreERT2 line
was then crossed with a ROSA-flox-stop-tdtomato line to
obtain a permanent reporter of Atf3 activity.
When examining the resulting mice for tdtomato sig-
nal, it became clear that the ATF3-CreERT2 construct
displays a small degree of TAM-independent “leakiness”.
Under normal circumstances, Atf3 is expressed in very
few regions of the adult nervous system [12]. We and
others have found that a small number of uninjured
sensory neurons express Atf3 [23], and evidence of rare
spontaneous recombination was found in reporter-
expressing trigeminal and spinal sensory neurons, and
their terminals in the spinal trigeminal nucleus and spinal
cord (Fig. 1b, c). Allen Brain Atlas in situ hybridization
data [24] show ATF3 expression only in granular neurons
of the olfactory bulb and dentate gyrus, and accordingly,
in naïve ATF3-CreERT2:stopfl/fltdtomato mice, occasional
reporter-expressing neurons were found in both of these
regions (Fig. 1d). We also found occasional clusters (prob-
ably clones) of microglia and vascular endothelial cells
throughout the brain (Fig. 1e). As would be expected in
the case of spontaneous Atf3 activation, recombination
events increased with age, ranging from 3 to 5 cells per
DRG in 8 week old mice to 10–20 cells in 7 month old
mice (data not shown).
TAM-induced Atf3 induction in cortical regions
Since TAM is known to have side effects of a cognitive na-
ture in cancer patients, we sought to investigate its effects
in relevant regions of the brain. The Allen Brain Atlas [24]
suggests that Atf3 is very sparsely expressed in the brain,
with only some labelling in the granule cell layers of the
olfactory bulb and dentate gurys (Fig. 2a). Indeed in
vehicle-treated ATF3-CreERT2:stopfl/fltdtomato animals,
an occasional Atf3 positive cell was present in these areas
due to the leakiness of the ERT2 construct (Figs. 2b and
1d). TAM administration resulted in wide-spread recom-
bination in granular neurons of the olfactory bulb and
dentate gyrus (Fig. 2b-d). Recombination also occurred
throughout the brain and spinal cord in vascular endothe-
lial, smooth muscle and ependymal cells (Fig. 2e), but not
in tanycytes lining the ventral part of the 3rd ventricle
(data not shown). In the olfactory bulb and dentate gyrus,
neuronal expression of reporter was confirmed by coloco-
lization of tdtomato with NeuN (olfactory bulb) and
NeuN/calbindin D28k (dentate gyrus) (Fig. 3a, b). Re-
porter expression was not simply due to TAM-induced
nuclear translocation of the ATF3-CreERT2 construct in
cells expressing Atf3 as the density of tdtomato-
expressing neurons was far higher than would be expected
based on Atf3 in situ hybridization data. Atf3 upregulation
was not associated with increased expression of pro-
apoptotic activated caspase 3: there were occasional dying
neurons in both regions, but these were never also
tdtomato-positive (Fig. 3c).
TAM-induced Atf3 induction in primary afferent neurons
TAM also induced high levels of tdtomato expression in
the DRG (Fig. 4). More than 20 % of neurons were af-
fected, even after a single intraperitoneal dose of TAM
at 75 mg/kg. Using an antibody to stain for Atf3, we
could show that noticeably elevated nuclear expression
was transient (Fig. 4a). Repeated dosing of mice with
TAM did not increase the number of recombined
neurons in the DRG beyond that which occurred after
a single 75 mg/kg i.p. injection (Fig. 4b), although the
number of ATF3-positive neuronal nuclei was notice-
ably increased 24 h after a third daily injection, indi-
cating that TAM repeatedly stresses otherwise healthy
neurons.
TAM-induced tdtomato expression occurred preferen-
tially in large diameter neurons, indicating that they may
be more vulnerable to cellular stress. This was confirmed
using analysis of cell size diameter (Fig. 4c), as well as co-
staining with markers for the four prominent mouse DRG
subpopulations [25] (Fig. 5): neurofilament 200 (NF200)
for large diameter mechanosensitive neurons; calcitonin
gene-related peptide (CGRP) and isolectin B4 (IB4) for
peptidergic and non-peptidergic nociceptors, respectively;
and tyrosine hydroxylase (TH) for a fourth small diameter
population (Fig. 5a–d). The vast majority of recombin-
ation occurred in NF200 positive neurons, with a small
percentage also in non-peptidergic IB4 positive noci-
ceptors (Fig. 5e). Other cell populations found to be
preferentially affected by TAM treatment were mesen-
cephalic trigeminal neurons that convey proprioceptive
information from the masseter (Fig. 5f), as well as vascular
endothelial, smooth muscle and ependymal cells (Fig. 5g).
In the spinal cord, primary afferent projections to Clarke’s
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Fig. 3 Characterization of recombined cells in the dentate olfactory bulb and dentate gyrus. a Olfactory bulb. recombined cells are neuronal, as
is evident from morphology and colocalization with NeuN (arrows). b Dentate gyrus. Here too, tdtomato-expressing cells express NeuN and the
dentate granule cell lineage marker calbindin D28k (Calb D28k). Asterisks indicate recombined endothelial cells. c Recombined neurons do not
undergo cell death. Very few cells in either the olfactory bulb or dentate gyrus expressed the pro-apoptotic marker activated caspase 3 (aCasp3)
or had condensed chromatin, and these were never tdtomato-positive. Shown is an example of a rare dying neuron from the dentate gyrus
(See figure on previous page.)
Fig. 2 a Allen Brain Atlas in situ hybridization studies of ATF3 mRNA expression in dentate gyrus and olfactory bulb. Sections are 25 μm thick.
b In the absence of TAM, a few neurons have undergone recombination in the granular layer of the OB; with TAM, recombination is widespread
and is far more than expected from Allen Brain Atlas ATF3 in situ hybridization studies. Insets are shown enlarged on the right. c–e TAM induces
recombination in DG granule neurons, ependymal cells of the cerebral ventricles, in endothelial cells and in vascular smooth muscle cells (arrows
in e). All sections (except those from the Allen Institute) are 30 μm thick and are single-plane images taken on a standard epifluorescence
microscope. TAM: TAM. DG: dentate gyrus. OB: olfactory bulb. Image credit a: Allen Institute for Brain Science
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Fig. 4 TAM (TAM) induces transient ATF3 upregulation and recombination in the DRG. a (left), tdtomato and ATF3 expression from a cervical
DRG, 4 days after a single 75 mg/kg TAM injection (single 1 μm-thick confocal plane). a (right), ATF3 expression in the trigeminal ganglion at
various timepoints following TAM (single optical planes). The inset in shows quantitative differences in the number of ATF3-positive nuclei per 400 ×
400 μm single optical section. Each point represents a single image (four each from three animals per timepoint). b The proportion of neurons undergoing
recombination after TAM does not increase with repeated daily dosing. Main panels are 1 μm-thick optical sections, insets are 30 μm-thick stacks from the
same fields of view. The far-right image is from a TAM-treated advillin-CreERT2:stopfl/fltdtomato mouse, in which recombination occurs in nearly all DRG
neurons. c Size-frequency distribution analysis reveals that after TAM treatment, recombined neurons tend to be larger (there is a rightward shift in the
distributions p< 0.05, Kolmogorov-Smirnov goodness-of-fit test). SFO: sunflower oil, the TAM vehicle
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column (a proprioceptive relay to the cerebellum) were
particularly dense.
ChEH inhibition accounts for Atf3 induction by TAM
Next, we sought to determine by which mechanism TAM
might induce cellular stress. We chose to use the DRG as
a model since DRGs can be imaged rapidly as whole-
mounts. TAM binds not only the mutated estrogen recep-
tor (ERT2), but also endogenous ERα, the ChEH enzyme
complex and the sigma1/2 receptors. TAM binding to
ChEH inhibits the enzyme’s activity, resulting in the accu-
mulation of cholesterol-5,6-epoxides and the inhibition of
cholestane-3β,5α,6β-triol production [26]. To test the hy-
pothesis that TAM-mediated accumulation of the ChEH
substrate leads to Atf3 expression we took advantage of
the fact that α-tocopherol (vitamin E) prevents the accu-
mulation of cholesterol epoxides. Sunflower oil (SFO)
contains approximately 40 mg/100 g α-tocopherol, while
wheat germ oil (WGO) contains ~150 mg/100 g, nearly
four times as much [15]. Therefore, we pre- and post-
treated mice with i.p. WGO on the days before and after
TAM treatment. We used two doses: either 0.25 ml or
0.5 ml, corresponding to 6.4125 or 12.825 IU/kg, and used
it as the TAM vehicle (these non-toxic doses were
chosen based on previous efficacy and toxicological stud-
ies of α-tocopherol in mice [16]). With either WGO
schedule there was a drastic and statistically significant re-
duction in the number of recombined neurons in the
DRG (Fig. 6a, b). We also attempted to deliver vitamin E
directly in SFO, which was less successful at preventing
TAM-induced Atf3 expression (Fig. 6c). This was likely
due to increased variability as a result of the difficulties
encountered when attempting to dissolve vitamin E evenly
in SFO. Nevertheless, we found that the mean recombin-
ation frequency was consistently decreased in all tissues
examined (dentate gyrus, olfactory bulb, and DRG, data
not shown).
Finally, we asked directly whether activation of the
ChEH complex can induce recombination in naïve
ATF3-CreERT2:stopfl/fltdtomato mice. We injected ani-
mals with a single intraperitoneal dose of the selective
ChEH ligand DPPE (50 mg/kg) [21], and compared re-
combination to saline treated animals. A significant in-
crease in tdtomato positive cells occurred (Fig. 6d and
Table 2), supporting the idea that ChEH inhibition is
responsible for TAM-induced Atf3 upregulation. The
overall density of recombined cells in DPPE-treated mice
was far less than that of TAM (in SFO)-treated animals.
This was expected, since DPPE cannot induce active nu-
clear translocation of the ERT2 construct and tdtomato
induction is therefore entirely reliant on leaky nuclear
translocation of CreERT2.
Since some primary afferent neurons express ERα as
well as the sigma-1 receptor [27, 28], we also assessed
their putative roles in this context. We treated mice
with either ICI 182,780, a “pure” antiestrogen [17],
4,4′,4″-(4-Propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol
(PPT), a potent ERα agonist [18], or ditolylguanidine
(DTG), a sigma-1 and −2 receptor agonist. These drugs
were given the day prior, on the day of, and the day follow-
ing TAM treatment (75 mg/kg). None of these com-
pounds induced recombination if given alone (data not
shown), and none significantly altered the proportion of
DRG neurons which underwent recombination (Fig. 6b).
Drug doses and animal numbers are listed in Table 1.
As was observed in the DRG, administration of TAM
in WGO considerably decreased the ATF3 expression
induced by the compound across most affected cell types
and brain regions. Reduced recombination was particu-
larly striking in the dentate gyrus of the hippocampus
(Fig. 7a, b). Again, DPPE partially mimicked the effects
of TAM in this area (Fig. 7c), suggesting an important
role for ChEH inhibition in Atf3 activation. Quantifica-
tion of these effects is provided in Fig. 7d and Table 2.
Discussion
This is the first study to directly assess the effects of TAM
on cellular stress-induced Atf3 expression in the nervous
system. We show that granular neurons of the olfactory
bulb and dentate gyrus, a subpopulation of sensory neu-
rons, ependymal cells and endothelial and vascular smooth
muscle cells upregulate Atf3 in response to a single
75 mg/kg dose of TAM. In addition, we show that TAM
does not induce Atf3 via estrogen receptors or sigma 1/2
receptors in these cells. Instead, our results indicate that
ChEH is the responsible TAM-binding entity: Atf3 induc-
tion is reduced when TAM is delivered in vitamin E rich
wheat germ oil and, conversely, direct activation of ChEH
using the selective ligand DPPE upregulates Atf3. Whether
this is due to accumulation of cholesterol epoxides (ChEH
(See figure on previous page.)
Fig. 5 Phenotypic distribution of ATF3-expressing DRG neurons after TAM treatment. a NF200, expressed by large diameter mechanosensory
DRG neurons. Arrowhead indicates a few NF200-negative profiles. b CGRP, expressed by peptidergic nociceptors. c IB4 lectin binding by
non-peptidergic nociceptors, doubly-labeled cells are indicated by arrows. d TH expression by small diameter DRG neurons. e Quantification
of marker expression by tdtomato-positive neurons. The vast majority of recombined DRG neurons express NF200. f Trigeminal mesencephalic
proprioceptive neurons also undergo recombination with TAM treatment. g Central projections of recombined neurons are most dense in the
ascending dorsal columns and in Clarke’s column (arrow). Other recombined structures are vascular endothelial and smooth muscle cells and
ependymal cells (see also Fig. 2). All images are single confocal planes
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ligands) or reduction in the synthesis of cholestane-
3β,5α,6β-triol remains unknown, although the anti-cancer
effects of TAM in estrogen-insensitive breast tumors are
thought to be attributable to the former [11, 26, 29].
In the cortex, we found TAM to induce recombination in
granular neurons of the dentate gyrus of the hippocampus
and olfactory bulb, as well as in vascular and ependymal
cells. Taking previous findings and our results at face value,
they would suggest that recombined neurons in the
dentate gyrus occupy relatively superficial positions in
the granular cell layer. Both during development and in
adulthood, dentate granule neurons are born in an
Fig. 6 TAM induction of ATF3 expression occurs via ChEH inhibition. a Schematic indicating TAM targets (ERα: estrogen receptor alpha; σ1/σ2:
sigma 1/2 receptors; ChEH: cholesterol-5,6-epoxide hydrolase), ChEH ligands (DPPE) and drugs used: ICI: ICI 182 780, a pure antiestrogen (n =
3); PPT: 4,4′,4″-(4-Propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol, an ERα agonist (n = 3); DTG: ditolylguanidine, a sigma 1/2 receptor agonist (n = 3),
vE: vitamin E. CE: ChEH substrate cholesterol epoxides; CT: ChEH products cholestane triol. b effects of SFO, WGO and drugs on recombination
in the DRG. SFO: sunflower oil (n = 5); WGO: wheat germ oil (n = 4); vE: vitamin E (n = 6). c Only wheat germ oil significantly reduced recombination
(P < 0.0001, one-way ANOVA). Note the decreased mean but increased variability in animals in which SFO was supplemented with vitamin E. d A single
dose of DPPE, a selective ChEH ligand, induced significant recombination in the DRG
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outside-out manner [8, 30], implying that those which
are most susceptible to TAM-induced Atf3 upregula-
tion are more mature cells.
A previous investigation of TAM-induced toxicity at
therapeutic doses in the brain revealed a loss of oligo-
dendrocyte progenitor cells (OPCs) in the corpus callo-
sum [7]. This was accompanied by a reduction in their
proliferation, and that of neural progenitors in the sub-
ventricular zone and dentate gyrus, and it was sug-
gested that this may represent a cellular substrate of
cognitive dysfunction experienced by breast cancer pa-
tients receiving TAM therapy. OPC loss was prevented
both in vitro and in vivo by MEK1/2 inhibition, one of
a number of intracellular messengers that can activate
Atf3 expression [12]. In contrast, we found no evidence
of TAM-induced recombination in OPCs or in the dee-
per neurogenic regions of the dentate gyrus or subven-
tricular zone. It is possible that the reported OPC loss
occurs independent of Atf3 induction, and although
our study does not rule out effects of TAM on neuro-
genesis, it does not support a role for Atf3 in this
process. Together these data indicate pleiotropic effects of
TAM on dentate granule neurons, one involving MEK1/2
activation in immature neural cells (neuronal and glial
progenitors), the other reliant upon Atf3 upregulation
induced by ChEH inhibition in older adult-born neurons.
One point to take away from our studies in particular
is that patients prescribed tamoxifen take the medication
on a daily basis. We found that a single tamoxifen dose
induced ATF3 expression, albeit transiently, in several
populations of neurons. Our data show that ATF3 ex-
pression can be maintained in susceptible neurons with
repeated daily dosing (Fig. 4), the downstream effects of
which are unknown, but likely to be of biological and
clinical significance.
TAM also induced Atf3 upregulation in sensory neu-
rons, which was particularly marked in large propriocep-
tive NF200 positive cells in the trigeminal mesencephalic
nucleus and in those projecting to Clarke’s column in
the spinal cord, and to a much lesser extent in non-
peptidergic IB4 positive neurons. It is tempting to specu-
late that large fibres have higher metabolic demands and
might therefore be more vulnerable to cellular stress.
The pattern of induction is certainly evocative of a large
fibre neuropathy, which is known to accompany non-
hormonal chemotherapy with platinum-based drugs
[31] and has been linked to mitochondrial dysfunction.
However, with the exception of rare optic neuropathies
[32, 33], we can find no evidence in the literature that
TAM treatment results in any sensory disturbances.
This could be because Atf3 in the peripheral nervous
system is associated with a robust reparative response
after stressors such as axotomy. Atf3 is among the earliest
genes to be upregulated after axonal injury [34], and is as-
sociated with successful regeneration: it is robustly induced
in regeneration-competent sensory neurons by peripheral
nerve injury [35] but not by injury to centrally-projecting
dorsal roots [36]. Furthermore, genetic overexpression of
Atf3 in sensory neurons improves the regenerative re-
sponse to peripheral nerve injury [37, 38].
Beyond its therapeutic use in breast cancer, TAM has
been exploited experimentally to induce permanent re-
porter expression in, for example, newly-born neurons in
the olfactory bulb and dentate gyrus [8], in physiologically-
active neurons throughout the brain [9], and in progeny of
ependymal cells of the intact and injured murine spinal
cord [39]. In each of these examples, the use of TAM to
induce recombination may have profound consequences
on interpretation of the data.
In the Imayoshi study [8], very large doses (400 mg/
kg) were administered daily for 4 days, a regimen that
was repeated twice more in some experiments. What is
absent, however, both in anatomical and behavioural
experiments assessing the role of newly-generated hip-
pocampal neurons in memory formation/retention, is a
TAM-only control in wild-type mice. Based on our re-
sults, TAM treatment would (repeatedly) induce cellu-
lar stress in older neurons, the effect of which on the
neurogenic process remains unknown.
The Guenthner study [9] used a genetic labeling
technique nearly identical to ours, but recombination
was driven by promoters for the immediate-early genes
Fos and Arc, upregulated as part of the “excitation-tran-
scription” neuronal response to synaptic activity initiated
by CREB phosphorylation [40]. TAM-induced recombin-
ation in the dentate gyrus and olfactory bulb, particularly
when recombination was dependent upon Arc expres-
sion, was remarkably similar to what we show here
(Figs. 5 and 7), both in terms of number of neurons
recombined and dorso-ventral distribution in the granu-
lar cell layer of the dentate gyrus. In these regions
particularly it is unclear to what extent neuronal activity
Table 2 DPPE, a selective ChEH ligand, significantly increased recombination in the DRG, hippocampus and olfactory bulb
Tissue Saline DPPE p value Analysis details
DRG 12.33 +/− 2.33 26.00 +/− 3.21 0.026 Neurons per DRG whole-mount, 2 cervical DRG/ n
Dentate gyrus 1.17 +/− 0.44 8 +/− 0.58 0.001 Granule cell neurons per section, 4 sections/ n,
anterior dentate gyrus at the level of the median eminence
Olfactory bulb 2 +/− 0.58 12.33 +/− 1.45 0.003 Granule cell neurons per 150 × 500 micron field, mid-OB
Data represent mean +/− SE, n = 3 mice per group
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Fig. 7 (See legend on next page.)
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per se was driving recombination, or whether TAM
induced Arc expression via cellular stress as it does
expression of Atf3.
Our data show that ependymal cells are particularly
prone to TAM-induced Atf3 upregulation. This may have
important ramifications for the interpretation of a study
by Barnabé-Heider et al. [39]. Here, five daily treatments
of TAM (80 mg/kg) were used to induce recombination in
ependymal cells in FoxJ1-CreER mice in order to deter-
mine whether ependymal cells are multipotential in vitro,
and in vivo following a spinal cord injury. The in vitro
studies showed that 3 days after cessation of TAM treat-
ment, recombined ependyma could indeed give rise to
neurospheres with cells expressing markers for neurons,
astrocytes and oligodendrocyte-lineage cells. In vivo,
reporter-expressing ependyma self-renewed and produced
astrocytes and oligodendrocyte-lineage cells 5 days follow-
ing the last TAM dose. Again, what remains unknown is
the effect that TAM-induced cellular stress has on the
multipotentiality of ependymal cells, and thus on the
interpretation of the results.
In all three of the above studies, TAM was delivered in
corn oil, which has a vitamin E content of ~14.3 mg/
100 g, compared to ~40 mg/100 g in SFO and ~150 mg/
100 g in WGO. ChEH inhibition, which is complete even
at lower (therapeutic) doses of TAM [11], is thus likely to
have contributed significantly to the observed effects.
Conclusions
The ATF3-CreERT2 mice we have generated have
allowed the first glimpse into the cellular stress pathway
elicited in the central nervous system by TAM. They
have revealed that TAM induces Atf3 expression in CNS
and PNS neurons, vasculature and ependyma by inter-
fering with cholesterol biosynthesis, an important issue
when considering the use of ChEH inhibitors (such as
DPPE) in the treatment of cancer. They also give cause
for caution when interpreting experiments using the
Cre-ERT2 system to manipulate gene expression. Our
finding that vitamin E prevents TAM-induced cellular
stress represents a solution to this previously unappreci-
ated experimental confound.
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